Food and Beverage Production

Ajinomoto Co., Inc.

Ajinomoto to Invest 1.2B JPY to Build Semiconductor Packaging Material Factory

Palliser Capital Acquires Ajinomoto Shares to Focus on Japanese AI Investment Opportunities

PALLISER Acquires Shares in Ajinomoto, Becomes One of Its Top 25 Shareholders

Palliser Acquires Shares in Ajinomoto and Demands Price Increase for Semiconductor Insulation Materials

Ajinomoto Expands Recall of Frozen Meals

2802

Ajinomoto Co. Inc. reported record sales of JPY 1.530 trillion and business profit of JPY 159.3 billion for FY 2024, with strong overseas demand and growth in Bio-Pharma services. The company plans a JPY 100 billion share repurchase and a dividend increase for FY 2025, forecasting sales of JPY 1.618 trillion and a 13% rise in business profit. Despite challenges in Japan's frozen foods segment and restructuring costs, Ajinomoto remains confident in its growth strategy and shareholder returns.

Tip Ranks

Ajinomoto Co. Inc. Signals Confident FY 2025 Outlook

Ajinomoto Foods North America has appointed Dave Gardner as President and CEO, effective April 1, 2026. Gardner, previously the Chief Supply Chain Officer, will lead the company through its next growth phase, succeeding Hiroshi Kaho. With over 35 years of experience, Gardner aims to enhance operational excellence, accelerate innovation, and develop future leaders. He emphasizes the company's commitment to creating culturally inspired frozen foods that promote well-being. Under his leadership, AFNA seeks to strengthen its market presence in the growing frozen food sector, particularly in Asian and multicultural offerings.

prnewswire

Ingredion

09:05 ETAjinomoto Foods North America Names Dave Gardner President and CEO to Lead Next Phase of Growth and Innovation

The global Fiber and Specialty Carbohydrate Market is projected to grow from USD 15 billion in 2025 to USD 26.1 billion by 2035, with a CAGR of 5.7%. Key drivers include rising consumer awareness of digestive health and preventive nutrition, leading to increased integration of fibers in functional foods and beverages. The market faces challenges such as allergen concerns and regulatory compliance. Europe is the dominant region, with the UK expected to grow the fastest. Major players include Ajinomoto, Cargill, and DSM, focusing on innovation and sustainable sourcing.

10:16 ETFiber and Specialty Carbohydrate Market to Reach USD 26.1 Billion by 2035 as Functional Foods, Preventive Nutrition, and Plant-Based Ingredient Demand Accelerate Global Growth | FMI Report

Ajinomoto (TSE:2802) reported strong full-year results for the period ending March 31, 2026, with sales of ¥1,583,719 million and net income of ¥134,675 million. The stock has shown significant returns, with a 22.71% increase over 90 days and 57.05% over a year. Analysts suggest the stock is about 2% overvalued at ¥5,030 compared to a fair value of ¥4,932, while a DCF model indicates it may be undervalued at ¥5,030 against a future cash flow value of ¥5,359. Key risks include raw material cost inflation and market weaknesses in Nigeria and Thailand.

Simplywall

Ajinomoto (TSE:2802) Valuation Check After Strong Full Year Earnings And Profit Growth

Ajinomoto Foods North America has partnered with The St. James to enhance athlete well-being through nutrition and performance. This collaboration aims to support athletes balancing training and daily life, emphasizing the importance of nutrition in achieving peak performance. The partnership will include on-site activations and programs at The St. James, a premier sports and wellness complex. Ajinomoto's initiative, "The Well-Being Effect," focuses on shared meals and the role of food in fostering joy and connection. The partnership reflects a commitment to maximizing human potential through sports and wellness.

10:02 ETAjinomoto Foods North America and The St. James Bring Athlete Well-Being to Life Through Food and Performance

Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services have announced a strategic collaboration to enhance the development and manufacturing of antibody-drug conjugates (ADCs). This partnership will allow Piramal to refer clients seeking ADC manufacturing technology to Ajinomoto, which will in turn recommend Piramal as a potential CDMO for AJICAP™-based products. The collaboration aims to streamline the development process and improve access to ADC expertise, ultimately accelerating innovation and enhancing patient access to effective therapies.

13:12 ETPiramal Pharma Solutions und Ajinomoto Bio-Pharma Services arbeiten zusammen, um die Entwicklung und Herstellung von ADCs zu unterstützen

NVDA

SOXL

NVDL

SOXX

NVDY

NVDU

NVDX

The dominance of Ajinomoto in the ABF material market, crucial for AI chip packaging, is highlighted as it holds over 95% market share. The demand for ABF is surging due to the increasing complexity of AI accelerators, with projections indicating a significant supply shortfall by 2028. Ajinomoto plans to invest 25 billion yen to boost capacity by 50% by 2030, but uncertainties remain regarding whether this will meet the rapid growth in AI computing power. The situation is exacerbated by upstream material shortages, leading to potential market disruptions.

- The article discusses Ajinomoto's pivotal role in the semiconductor industry through its monopoly on Ajinomoto Build-up Film (ABF), essential for high-performance chip packaging.  
- Ajinomoto's market share exceeds 95%, which is critical amid rising AI demands that strain supply chains; shortages of ABF could lead to severe gaps by 2028.  
- Despite plans to boost capacity, the company's dominance presents risks, as fluctuations in both supply capabilities and strategic focus could impact the future of AI chip production significantly.

TradingKey

NVIDIA

Direxion Semicon Bull 3X

VanEck Semiconductor ETF

GraniteShares 2x Long NVDA Daily ETF

iShares Semiconductor ETF

YieldMax NVDA Option Income Strategy ETF

Direxion Daily NVDA Bull 2X Shares

T-Rex 2X Long NVIDIA Daily Target ETF

Intel

Sekisui Chemical Co., Ltd.

Morgan Stanley

Goldman Sachs

NVIDIA Corporation

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

GS Hldg R

How an MSG Factory Holds Nvidia by the Throat? What Is ABF Material?

Ajinomoto Co., Inc.(2802.JP)